Clinical & Experimental Metastasis

Papers
(The median citation count of Clinical & Experimental Metastasis is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis114
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches51
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression34
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics26
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria26
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics26
Oncolytic intralesional therapy for metastatic melanoma24
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption24
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG24
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss23
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection23
High sensitivity flow cytometry immunophenotyping increases the diagnostic yield of malignant pleural effusions22
Axillary nodal staging in breast cancer: what have we learned?21
Cell blebbing novel therapeutic possibilities to counter metastasis20
Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer19
Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis18
Correction: CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells17
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations17
Therapy resistance and metastasis16
Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer16
Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer16
Current preclinical models of brain metastasis15
CT-based deep learning model: a novel approach to the preoperative staging in patients with peritoneal metastasis15
Nectin-4 is frequently expressed in primary salivary gland cancer and corresponding lymph node metastases and represents an important treatment-related biomarker14
Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis14
Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model14
Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade14
Correction: SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells13
Etiology and treatment of cancer-related secondary lymphedema13
Efficacy and safety of PARPis combined with an ICIs for advanced or metastatic triple-negative breast cancer: a single-arm meta-analysis13
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis12
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations12
Histopathological growth patterns of neuroendocrine tumor liver metastases12
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study12
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?11
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK111
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results10
‘Sandwich treatment’ for posterior fossa brain metastases with volume larger than 4cm3: a multicentric retrospective study10
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation10
Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis9
Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy9
Correction: Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival9
Impact of time-of-day administration of immunotherapy on survival in metastatic renal cell carcinoma: the MOUSEION-09 meta-analysis9
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER29
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics9
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases8
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy8
Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma8
Immune responses and immunotherapeutic approaches in the treatment against cancer8
Stereotactic radiotherapy of nodal oligometastases from prostate cancer: a prisma-compliant systematic review7
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer7
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance7
Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors7
Correction to: Editorial: Cancer metastasis through the lymphovascular system: molecular mechanisms of cancer metastasis7
Interrogating the roles of lymph node metastasis in systemic immune surveillance7
TGFβ signalling pathway impacts brain metastases profiles in locally advanced colorectal cancer7
FTO mediated ERBB2 demethylation promotes tumor progression in esophageal squamous cell carcinoma cells7
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer7
Application of CTC discoveries for liquid biopsy: the RPL/RPS gene signature of melanoma CTCs is linked to brain metastasis onset7
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis6
CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling6
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?6
Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?6
International cooperation to fight cancer’s late-stage presentation in low- and middle-income countries6
Platycodin D represses β-catenin to suppress metastasis of cetuximab-treated KRAS wild-type colorectal cancer cells6
Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis6
Membrane Lipid Replacement for reconstituting mitochondrial function and moderating cancer-related fatigue, pain and other symptoms while counteracting the adverse effects of cancer cytotoxic therapy6
Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment6
Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study6
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review6
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review5
Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world5
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO)5
Review old bone, new tricks5
miRNAs in pancreatic cancer progression and metastasis5
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer5
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer5
Cancer metastasis through the lymphatic versus blood vessels5
Factors associated with the distribution of brain metastases in lung cancer: a retrospective study5
Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer5
Downregulation of LINC00886 facilitates epithelial–mesenchymal transition through SIRT7/ELF3/miR-144 pathway in esophageal squamous cell carcinoma5
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy5
Neoadjuvant therapy for resectable melanoma5
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer5
Detecting and monitoring tumors in orthotopic colorectal liver metastatic animal models with high-resolution ultrasound5
Associations amongst genes, molecules, cells, and organs in breast cancer metastasis5
0.092325925827026